ReviewAdvances in experimental medicine and biology2026
Infectious/Inflammatory Oral Diseases and Medication-Related Osteonecrosis of the Jaw (MRONJ).
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication-related osteonecrosis of the jaw (MRONJ) is a rare and potentially debilitating condition affecting patients treated with medications that inhibit bone resorption. It is characterized by exposed bone, usually in the mandible or maxilla, with clinical signs of inflammation, pain, and local infection. MRONJ is often triggered by invasive procedures in the oral cavity, such as dental extractions or trauma, and is associated with a predisposition to secondary infections. The interaction between MRONJ and oral infectious/inflammatory diseases, such as periodontal disease, apical periodontitis, and peri-implantitis, is complex, as oral infections lead to bone infection, exacerbating the bone necrosis characteristic of MRONJ. Furthermore, the inflammatory process of oral infections can worsen the patient's immune response and hinder the healing of bone lesions. The clinical management of patients with MRONJ resulting from oral infections requires a careful approach, with emphasis on strict control of the infection and preservation of periodontal health. Prevention and control of oral infections are essential to minimize the risk of complications and improve the patient's quality of life. This chapter addresses the relationship between MRONJ and different oral infections, presenting current aspects of this relationship and special care for its treatment.
Indexed as
Identifiers
41225109What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.